Literature DB >> 11746012

Neurobehavioral phenotype in carriers of the fragile X premutation.

C Johnston1, S Eliez, J Dyer-Friedman, D Hessl, B Glaser, C Blasey, A Taylor, A Reiss.   

Abstract

There have been contradictory findings in the fragile X (fraX) literature about possible neurocognitive and psychological symptoms due to the fraX premutation (pM). The purpose of the present study was to investigate the relationship between CGG repeat length and neurobehavioral functioning in carriers of the fraX pM. Eighty-five female carriers of the pM with allele sizes ranging from 59-166 were administered a comprehensive IQ test (WAIS-III) and completed a questionnaire designed to measure psychopathology (Symptom Checklist (SCL)-90-R). No relationship between allele size and cognition was identified. A significant negative relationship between allele size and age was found, as well as a positive relationship between allele size and depression. Follow-up analyses separating small and large allele sizes (below and above 100 CGG repeats) indicated that individuals with larger allele sizes scored significantly higher on the Interpersonal Sensitivity and Depression subscales of the SCL-90-R. Despite the limitation of few individuals with high CGG repeat lengths, our findings suggest that females with larger premutated alleles (> or = 100 repeats) display some clinical manifestations of fraX syndrome. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746012

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  43 in total

1.  Differential sensitivity to life stress in FMR1 premutation carrier mothers of children with fragile X syndrome.

Authors:  Marsha Mailick Seltzer; Erin T Barker; Jan S Greenberg; Jinkuk Hong; Christopher Coe; David Almeida
Journal:  Health Psychol       Date:  2011-12-12       Impact factor: 4.267

2.  Identification of expanded alleles of the FMR1 gene among high-risk population in Indonesia by using blood spot screening.

Authors:  Tri Indah Winarni; Agustini Utari; Farmaditya E P Mundhofir; Tzuhan Tong; Blythe Durbin-Johnson; Sultana M H Faradz; Flora Tassone
Journal:  Genet Test Mol Biomarkers       Date:  2011-10-11

Review 3.  Aripiprazole in autism spectrum disorders and fragile X syndrome.

Authors:  Craig A Erickson; Kimberly A Stigler; David J Posey; Christopher J McDougle
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 4.  A review of fragile X premutation disorders: expanding the psychiatric perspective.

Authors:  James A Bourgeois; Sarah M Coffey; Susan M Rivera; David Hessl; Louise W Gane; Flora Tassone; Claudia Greco; Brenda Finucane; Lawrence Nelson; Elizabeth Berry-Kravis; Jim Grigsby; Paul J Hagerman; Randi J Hagerman
Journal:  J Clin Psychiatry       Date:  2009-05-05       Impact factor: 4.384

5.  Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders.

Authors:  Andrea Schneider; Andreea Seritan; Flora Tassone; Susan M Rivera; Randi Hagerman; David Hessl
Journal:  Prim Care Companion CNS Disord       Date:  2013

6.  Broad autism spectrum and obsessive-compulsive symptoms in adults with the fragile X premutation.

Authors:  A Schneider; C Johnston; F Tassone; S Sansone; R J Hagerman; E Ferrer; S M Rivera; D Hessl
Journal:  Clin Neuropsychol       Date:  2016-06-29       Impact factor: 3.535

7.  Unaffected siblings of adolescents and adults with fragile X syndrome: Effects on maternal well-being.

Authors:  Lauren V Usher; Leann S DaWalt; Jan S Greenberg; Marsha R Mailick
Journal:  J Fam Psychol       Date:  2018-09-13

8.  Maternal well-being and child behavior in families with fragile X syndrome.

Authors:  Claire T Hauser; Sara T Kover; Leonard Abbeduto
Journal:  Res Dev Disabil       Date:  2014-06-29

9.  Psychological symptoms correlate with reduced hippocampal volume in fragile X premutation carriers.

Authors:  P E Adams; J S Adams; D V Nguyen; D Hessl; J A Brunberg; F Tassone; W Zhang; K Koldewyn; S M Rivera; J Grigsby; L Zhang; C Decarli; P J Hagerman; R J Hagerman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

10.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.